FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Gopal Kundu

Research Profile

Chemicals & Drugs

Physiology

Phenomena

Anatomy

Tumor Cell Line

Living Beings

Disorders

Concepts & Ideas

Biological Models

Procedures

Neoplasm Transplantation

Co-author Network

Publications

TOP 3
Goutam Chakraborty; Santosh Kumar; Rosalin Mishra; Tushar V Patil; Gopal C Kundu
Semaphorin 3A suppresses tumor growth and metastasis in mice melanoma model.
Mansoor Ahmed; Reeti Behera; Anuradha Bulbule; Goutam Chakraborty; Pompom Ghosh; Shalini Jain; Smita Kale; Rajinder Kaur; Dhiraj Kumar; Santosh Kumar; Vinit Kumar; Rosalin Mishra; Remya Raja; Anuja Ramdasi; Megha Sanyal; Supriya Saraswati; Priyanka Sharma; Gowrishankar Soundararajan; Dhanashri Thorat; Gopal C Kundu
Osteopontin: a potentially important therapeutic target in cancer.
Anuradha Bulbule; Supriya Saraswati; Gopal C Kundu
Status of research on matrix metalloproteinases (MMPs) in India.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Gopal Kundu (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Goutam Chakraborty; Santosh Kumar; Rosalin Mishra; Tushar V Patil; Gopal C Kundu
Semaphorin 3A suppresses tumor growth and metastasis in mice melanoma model.
PloS one 2012;7(3):e33633.
2011: Mansoor Ahmed; Reeti Behera; Anuradha Bulbule; Goutam Chakraborty; Pompom Ghosh; Shalini Jain; Smita Kale; Rajinder Kaur; Dhiraj Kumar; Santosh Kumar; Vinit Kumar; Rosalin Mishra; Remya Raja; Anuja Ramdasi; Megha Sanyal; Supriya Saraswati; Priyanka Sharma; Gowrishankar Soundararajan; Dhanashri Thorat; Gopal C Kundu
Osteopontin: a potentially important therapeutic target in cancer.
Expert opinion on therapeutic targets 2011;15(9):1113-26.
2011: Anuradha Bulbule; Supriya Saraswati; Gopal C Kundu
Status of research on matrix metalloproteinases (MMPs) in India.
Expert opinion on therapeutic targets 2011;15(6):671-5.
2010: Vinit Kumar; Reeti Behera; Kirti Lohite; Swapnil Karnik; Gopal C Kundu
p38 kinase is crucial for osteopontin-induced furin expression that supports cervical cancer progression.
Cancer research 2010;70(24):10381-91.
2010: Jay Prakash Singh; Sudarsan Tamang; Pattuparambil R Rajamohanan; N C Jima; Goutam Chakraborty; Gopal C Kundu; Sushma M Gaikwad; Mohamad I Khan
Isolation, structure, and functional elucidation of a modified pentapeptide, cysteine protease inhibitor (CPI-2081) from Streptomyces species 2081 that exhibit inhibitory effect on cancer cell migration.
Journal of medicinal chemistry 2010;53(14):5121-8.
2010: Reeti Behera; Vinit Kumar; Kirti Lohite; Swapnil Karnik; Gopal C Kundu
Activation of JAK2/STAT3 signaling by osteopontin promotes tumor growth in human breast cancer cells.
Carcinogenesis 2010;31(2):192-200.
2010: Priyanka Sharma; Santosh Kumar; Gopal C Kundu
Transcriptional regulation of human osteopontin promoter by histone deacetylase inhibitor, trichostatin A in cervical cancer cells.
Molecular cancer 2010;9():178.
2010: Mansoor Ahmed; Gopal C Kundu
Osteopontin selectively regulates p70S6K/mTOR phosphorylation leading to NF-kappaB dependent AP-1-mediated ICAM-1 expression in breast cancer cells.
Molecular cancer 2010;9():101.
2010: Devanshi Seth; Nympha B D'Souza El-Guindy; Minoti Apte; Montserrat Mari; Steven Dooley; Manuela Neuman; Paul S Haber; Gopal C Kundu; Agus Darwanto; Willem J de Villiers; A Vonlaufen; Z Xu; P Phillips; S Yang; D Goldstein; R M Pirola; J S Wilson; Anna Moles; Anna Fernández; Anna Colell; Carmen García-Ruiz; José C Fernández-Checa; Christoph Meyer; Nadja M Meindl-Beinker
Alcohol, signaling, and ECM turnover.
Alcoholism, clinical and experimental research 2010;34(1):4-18.
2008: Goutam Chakraborty; Shalini Jain; Tushar V Patil; Gopal C Kundu
Down-regulation of osteopontin attenuates breast tumour progression in vivo.
Journal of cellular and molecular medicine 2008;12(6A):2305-18.
2008: Shalini Jain; Goutam Chakraborty; Remya Raja; Smita Kale; Gopal C Kundu
Prostaglandin E2 regulates tumor angiogenesis in prostate cancer.
Cancer research 2008;68(19):7750-9.
2008: Goutam Chakraborty; Shalini Jain; Smita Kale; Remya Raja; Santosh Kumar; Rosalin Mishra; Gopal C Kundu
Curcumin suppresses breast tumor angiogenesis by abrogating osteopontin-induced VEGF expression.
Molecular medicine reports 2008;1(5):641-6.
2008: Goutam Chakraborty; Shalini Jain; Gopal C Kundu
Osteopontin promotes vascular endothelial growth factor-dependent breast tumor growth and angiogenesis via autocrine and paracrine mechanisms.
Cancer research 2008;68(1):152-61.
2007: Hema Rangaswami; Gopal C Kundu
Osteopontin stimulates melanoma growth and lung metastasis through NIK/MEKK1-dependent MMP-9 activation pathways.
Oncology reports 2007;18(4):909-15.
2007: Shalini Jain; Goutam Chakraborty; Anuradha Bulbule; Rajinder Kaur; Gopal C Kundu
Osteopontin: an emerging therapeutic target for anticancer therapy.
Expert opinion on therapeutic targets 2007;11(1):81-90.
2006: Goutam Chakraborty; Shalini Jain; Reeti Behera; Mansoor Ahmed; Priyanka Sharma; Vinit Kumar; Gopal C Kundu
The multifaceted roles of osteopontin in cell signaling, tumor progression and angiogenesis.
Current molecular medicine 2006;6(8):819-30.
2006: Shalini Jain; Goutam Chakraborty; Gopal C Kundu
The crucial role of cyclooxygenase-2 in osteopontin-induced protein kinase C alpha/c-Src/IkappaB kinase alpha/beta-dependent prostate tumor progression and angiogenesis.
Cancer research 2006;66(13):6638-48.
2006: Hema Rangaswami; Anuradha Bulbule; Gopal C Kundu
Nuclear factor inducing kinase: a key regulator in osteopontin- induced MAPK/IkappaB kinase dependent NF-kappaB-mediated promatrix metalloproteinase-9 activation.
Glycoconjugate journal 2006;23(3-4):221-32.
2006: Goutam Chakraborty; Hema Rangaswami; Shalini Jain; Gopal C Kundu
Hypoxia regulates cross-talk between Syk and Lck leading to breast cancer progression and angiogenesis.
The Journal of biological chemistry 2006;281(16):11322-31.
2006: Hema Rangaswami; Anuradha Bulbule; Gopal C Kundu
Osteopontin: role in cell signaling and cancer progression.
Trends in cell biology 2006;16(2):79-87.
2005: Riku Das; Subha Philip; Ganapati H Mahabeleshwar; Anuradha Bulbule; Gopal C Kundu
Osteopontin: it's role in regulation of cell motility and nuclear factor kappa B-mediated urokinase type plasminogen activator expression.
IUBMB life 2005;57(6):441-7.
2005: Hema Rangaswami; Anuradha Bulbule; Gopal C Kundu
JNK1 differentially regulates osteopontin-induced nuclear factor-inducing kinase/MEKK1-dependent activating protein-1-mediated promatrix metalloproteinase-9 activation.
The Journal of biological chemistry 2005;280(19):19381-92.
2004: Hema Rangaswami; Anuradha Bulbule; Gopal C Kundu
Nuclear factor-inducing kinase plays a crucial role in osteopontin-induced MAPK/IkappaBalpha kinase-dependent nuclear factor kappaB-mediated promatrix metalloproteinase-9 activation.
The Journal of biological chemistry 2004;279(37):38921-35.
2004: Riku Das; Ganapati H Mahabeleshwar; Gopal C Kundu
Osteopontin induces AP-1-mediated secretion of urokinase-type plasminogen activator through c-Src-dependent epidermal growth factor receptor transactivation in breast cancer cells.
The Journal of biological chemistry 2004;279(12):11051-64.
2004: Ganapati H Mahabeleshwar; Riku Das; Gopal C Kundu
Tyrosine kinase, p56lck-induced cell motility, and urokinase-type plasminogen activator secretion involve activation of epidermal growth factor receptor/extracellular signal regulated kinase pathways.
The Journal of biological chemistry 2004;279(11):9733-42.
2004: Subha Philip; Anuradha Bulbule; Gopal C Kundu
Matrix metalloproteinase-2: mechanism and regulation of NF-kappaB-mediated activation and its role in cell motility and ECM-invasion.
Glycoconjugate journal 2004;21(8-9):429-41.
2003: Ganapati H Mahabeleshwar; Gopal C Kundu
Tyrosine kinase p56lck regulates cell motility and nuclear factor kappaB-mediated secretion of urokinase type plasminogen activator through tyrosine phosphorylation of IkappaBalpha following hypoxia/reoxygenation.
The Journal of biological chemistry 2003;278(52):52598-612.
2003: Riku Das; Ganapati H Mahabeleshwar; Gopal C Kundu
Osteopontin stimulates cell motility and nuclear factor kappaB-mediated secretion of urokinase type plasminogen activator through phosphatidylinositol 3-kinase/Akt signaling pathways in breast cancer cells.
The Journal of biological chemistry 2003;278(31):28593-606.
2003: Yasunari Takada; Asok Mukhopadhyay; Gopal C Kundu; Ganapati H Mahabeleshwar; Sujay Singh; Bharat B Aggarwal
Hydrogen peroxide activates NF-kappa B through tyrosine phosphorylation of I kappa B alpha and serine phosphorylation of p65: evidence for the involvement of I kappa B alpha kinase and Syk protein-tyrosine kinase.
The Journal of biological chemistry 2003;278(26):24233-41.
2003: Subha Philip; Gopal C Kundu
Osteopontin induces nuclear factor kappa B-mediated promatrix metalloproteinase-2 activation through I kappa B alpha /IKK signaling pathways, and curcumin (diferulolylmethane) down-regulates these pathways.
The Journal of biological chemistry 2003;278(16):14487-97.
2003: Ganapati H Mahabeleshwar; Gopal C Kundu
Syk, a protein-tyrosine kinase, suppresses the cell motility and nuclear factor kappa B-mediated secretion of urokinase type plasminogen activator by inhibiting the phosphatidylinositol 3'-kinase activity in breast cancer cells.
The Journal of biological chemistry 2003;278(8):6209-21.
2001: Subha Philip; Anuradha Bulbule; Gopal C Kundu
Osteopontin stimulates tumor growth and activation of promatrix metalloproteinase-2 through nuclear factor-kappa B-mediated induction of membrane type 1 matrix metalloproteinase in murine melanoma cells.
The Journal of biological chemistry 2001;276(48):44926-35.